Status:
UNKNOWN
Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICI
Lead Sponsor:
Assiut University
Conditions:
Non Small Cell Lung Cancer Metastatic
Diabetes Mellitus
Eligibility:
All Genders
Brief Summary
Retrospectively investigating the effect of DM on response rate and outcomes during immunotherapy treatment in patients with NSCLC in the last 5 years.
Detailed Description
Lung cancer continues to be the most common cause of cancer-related death worldwide for both males and females despite the identification of clinically-actionable driver mutations in genomic subgroups...
Eligibility Criteria
Inclusion
- All consecutive patients with advanced Non Small Cell Lung Cancer who received Immune Check Inhibitors alone or in combination with chemotherapy, either as first line or as a subsequent line
Exclusion
- None
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06100796
Start Date
October 1 2023
End Date
December 31 2024
Last Update
October 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt, 71515